Kingdon Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-893,580
Closed -$7.35M 96
2021
Q2
$7.35M Sell
893,580
-175,000
-16% -$1.49M 1.12% 41
2021
Q1
$9.56M Hold
1,068,580
1.51% 36
2020
Q4
$12.3M Hold
1,068,580
1.96% 22
2020
Q3
$11.1M Sell
1,068,580
-101,315
-9% -$1.24M 1.6% 25
2020
Q2
$15.4M Buy
1,169,895
+280,317
+32% +$2.91M 2.28% 20
2020
Q1
$7M Sell
889,578
-94,346
-10% -$1.42M 1.38% 29
2019
Q4
$20.4M Hold
983,924
3.83% 11
2019
Q3
$13.5M Buy
983,924
+55,000
+6% +$653K 2.04% 27
2019
Q2
$11.4M Buy
928,924
+44,906
+5% +$518K 1.49% 29
2019
Q1
$11M Buy
884,018
+300,000
+51% +$4.01M 1.57% 28
2018
Q4
$6.61M Buy
584,018
+9,535
+2% +$149K 1.15% 39
2018
Q3
$10.7M Sell
574,483
-514,737
-47% -$11.8M 1% 51
2018
Q2
$28.2M Buy
1,089,220
+203,000
+23% +$5.27M 2.42% 10
2018
Q1
$19.9M Hold
886,220
1.71% 17
2017
Q4
$22.2M Buy
886,220
+2,899
+0.3% +$71K 1.96% 20
2017
Q3
$21.4M Sell
883,321
-70,548
-7% -$1.66M 1.73% 18
2017
Q2
$19.3M Sell
953,869
-137,182
-13% -$2.86M 1.66% 26
2017
Q1
$29.4M Sell
1,091,051
-288,435
-21% -$5.89M 2.22% 16
2016
Q4
$26.2M Buy
1,379,486
+311,865
+29% +$5.96M 1.81% 26
2016
Q3
$20.9M Sell
1,067,621
-29,842
-3% -$505K 1.37% 26
2016
Q2
$16.4M Buy
1,097,463
+437,000
+66% +$5.49M 1.33% 32
2016
Q1
$6.08M Sell
660,463
-109,440
-14% -$1.33M 0.47% 68
2015
Q4
$14.8M Sell
769,903
-65,822
-8% -$1.14M 1.12% 47
2015
Q3
$12.4M Sell
835,725
-232,415
-22% -$5.45M 1.01% 49
2015
Q2
$23.4M Buy
1,068,140
+36,500
+4% +$736K 1.36% 35
2015
Q1
$23.2M Sell
1,031,640
-5,849
-0.6% -$135K 1.4% 22
2014
Q4
$20.9M Buy
1,037,489
+464,132
+81% +$8.41M 1.12% 34
2014
Q3
$10.5M Buy
573,357
+58,891
+11% +$853K 0.68% 60
2014
Q2
$6.91M Buy
514,466
+113,566
+28% +$1.55M 0.36% 102
2014
Q1
$6.59M Buy
+400,900
New +$6.93M 0.46% 86

Other funds holding FLXN